Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Clin Pathol ; 154(3): 387-393, 2020 08 05.
Article in English | MEDLINE | ID: mdl-32525523

ABSTRACT

OBJECTIVES: We sought to make pathologists' intraoperative consultation (IOC) results immediately available to the surgical team, other clinicians, and laboratory medicine colleagues to improve communication and decrease postanalytic errors. METHODS: We created an IOC report in our stand-alone laboratory information system that could be signed out prior to, and independent of, the final report, and transfer immediately to the electronic health record (EHR) as a preliminary diagnosis. We evaluated two metrics: preliminary (IOC) result review in the EHR by clinicians and postanalytic errors. RESULTS: We assessed 2,886 IOC orders from the first 22 months after implementation. Clinicians reviewed 1,956 (68%) of the IOC results while in preliminary status, including 1,399 (48%) within the first 24 hours. We evaluated 150 cases preimplementation and 300 cases postimplementation for discrepancies between the pathologist's IOC result and the IOC result recorded by the surgeon in the operative note. Discrepancies dropped from 12 of 150 preimplementation to 6 of 150 and 7 of 150 in postimplementation years 1 and 2. One of the 25 discrepancies had a major clinical impact. CONCLUSIONS: Real-time reporting of IOC results to the EHR reliably transmits results immediately to clinical teams. This strategy reduces but does not eliminate postanalytic interpretive errors by clinical teams.


Subject(s)
Frozen Sections , Pathology , Referral and Consultation , Communication , Electronic Health Records , Humans , Intraoperative Period
2.
Transfusion ; 60(2): 351-357, 2020 02.
Article in English | MEDLINE | ID: mdl-31919871

ABSTRACT

BACKGROUND: Two extracorporeal photopheresis (ECP) instruments, the CELLEX and the UVARXTS are currently being used "off-label" in the US for treatment of graft versus host disease (GVHD). Our study compared the performance of the two instruments in the setting of acute and chronic GVHD. STUDY DESIGN AND METHODS: We retrospectively analyzed the outcomes of patients with steroid refractory or steroid resistant GVHD undergoing ECP at Barnes Jewish Hospital. Multivariate logistic regression was used to evaluate the comparative efficacy of the two instruments with respect to steroid dose reduction (≥50% from baseline) and clinical improvement in GVHD. Chi-square/Fisher exact tests were used to compare the incidence of adverse events, while multivariate Cox regression was employed to assess a potential difference in mortality between the two instrument treatment cohorts. RESULTS: After adjusting for potential confounders, there was no significant difference in the odds of steroid dose reduction (OR = 1.41, 95% confidence interval [CI]: 0.51-3.90, p = 0.50) or clinical improvement (OR 2.0, 95% CI: 0.63-6.41, p = 0.24) between the two instrument treatment cohorts. The frequency of adverse events (CELLEX 45.4%; UVAR XTS 40.5%, p = 0.55) was also comparable between the cohorts. There was no significant difference in mortality of either acute or chronic GVHD patients when treated by the CELLEX as compared to the UVAR-XTS (aHR 0.66, 95% CI: 0.35-1.25, p = 0.20). CONCLUSION: The efficacy and safety of the two ECP instruments, the CELLEX and the UVAR-XTS, are comparable for the treatment of acute and chronic GVHD.


Subject(s)
Graft vs Host Disease/therapy , Photopheresis/instrumentation , Photopheresis/methods , Acute Disease , Chronic Disease , Female , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Proportional Hazards Models , Retrospective Studies
3.
Gynecol Oncol Rep ; 30: 100503, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31656851

ABSTRACT

Primary vaginal leiomyosarcoma (LMS) is a rare entity with limited data on optimal treatment approach. Most previously reported cases utilize an open or transvaginal surgical approach for primary tumor resection. Minimally invasive surgery is an important tool in complex pelvic surgery and the limits of its utility continue to expand. Here, we report a rare case of an 11.7 cm primary vaginal LMS in a 45-year-old female that was successfully resected with a robotic approach. Our case demonstrates an innovative use of the robot and the feasibility and efficacy of this approach for primary resection of large vaginal tumors.

4.
Indian J Pathol Microbiol ; 60(3): 421-423, 2017.
Article in English | MEDLINE | ID: mdl-28937388

ABSTRACT

Amyloid mesenteric angiopathy is difficult to diagnose as gastrointestinal (GI) signs are nonspecific and radiological studies rarely identify amyloid deposits with certainty. The objective of this study was to highlight the pathological findings of amyloid mesenteric angiopathy in cases of senile systemic amyloidosis. Literature review, author's research data, and practice experience were used. Systemic amyloidosis should be considered in the differential diagnoses when evaluating nonspecific and unexplained GI in patient population aged> 55 years to decrease the morbidity and fatal outcomes.


Subject(s)
Cerebral Amyloid Angiopathy/diagnosis , Cerebral Amyloid Angiopathy/pathology , Mesenteric Arteries/pathology , Aged , Aged, 80 and over , Fatal Outcome , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...